期刊文献+

溶瘤腺病毒治疗膀胱癌进展 被引量:1

Advancement on Oncolytic Adenovirus Therapy for Bladder Cancer
暂未订购
导出
摘要 溶瘤腺病毒是通过基因工程改变部分生物学特性的腺病毒。因其可以复制、增殖,最后裂解膀胱癌细胞而成为治疗膀胱肿瘤新的研究方向。为了使其具有更好的特异性、靶向性和安全性,人们进行了从改变单个基因到改变多个基因又到插入特异性启动子构建不同的溶瘤腺病毒治疗膀胱癌的研究,虽然还有很多问题有待解决,但已经取得了一定的成果。 Oncolytic adenovirus is an adenovirus whose partial biological characteristics is changed through the genetic engineering.It offers a new method of treating bladder cancer,because it can replicates and proliferates in the bladder cancer cell and fragments the cell at the end.In order to make it has better specificity,targeting and safety,people construct many kinds of oncolytic adenovirus by changing single gene or multiple gene or inserting specific promoters to take researches of treating bladder cancer.Although it remains lots of problems,but a certain achievements have been accomplished.
出处 《医学综述》 2011年第16期2441-2444,共4页 Medical Recapitulate
基金 国家自然科学基金(30973443) 徐州市科技计划项目(XZZD0708)
关键词 膀胱癌 溶瘤腺病毒 基因 Bladder Cancer Oncolytic Adenovirus Gene
  • 相关文献

参考文献22

  • 1Hsieh JL,WU CL,Lai MD,et al.Hepatitis B virus X protein sensitizes hepatocellular carcinoma cell to cytolysis induced by E1B-deleted adenovirus through the disruption of p53 function[J].Clin Cancer Res,2003,9(1):338-345.
  • 2Hsieh JL,Wu CL,Lai MD,et al.Gene therapy for bladder cancer using E1B-55kD-deleted adenovirus in combination with adenoviral vector encoding plasminogen kringles 1-5[J].Cancer Res,2003,88(9):1492-1499.
  • 3Fueyo J,Gomez-Manzano C,Alemany R,et al.A mutant oncolytic adenovirus targeting the Rb pathway produces anti-g lioma effect in vivo[J].Oncogene,2000,19(1):2-12.
  • 4Wang H,Satoh M,Abe H,et al.Oncolytic viral therapy by bladder instillation using an E1A,E1B double-restricted adenovirus in an orthhotopic bladder cancer model[J].Urology,2006,68(3):674-681.
  • 5Terao S,Shirakawa T,Kubo S,et al.Midkine promoter-based conditionally replicative adenovirus for targeting midkine-expressing hunman bladder cancer model[J].Urology,2007,70(5):1009-1013.
  • 6Shirakawa T,Hamada K,Zhang Z,et al.A cox-2 promoter-based replication-selective adenoviral vector to target the cox-2-expressing human bladder cancer cells[J].Clin Cancer Res,2004,10(13):4342-4348.
  • 7Gidekel S,Pizov G,Bergamn Y,et al.Oct-3/4 is a dose-dependent oncogenic fate determinant[J].Cancer Cell,2003,4(5):361-370.
  • 8Atlasi Y,Mowla SJ,Ziaee SA,et al.Oct-4,an embryonic stem cell marker,is highly expressed in bladder cancer[J].Int J Cancer,2007,120(7):1598-1602.
  • 9Wu CL,Shieh GS,Chang CC,et al.Tumor-selective replication of an oncolytic adenovirus carrying Oct-3/4 response elements in murine metastatic bladder cancer model[J].Clin Cancer Res,2008,14(4):1228-1238.
  • 10Ramesh N,Ge Y,Ennist DL,et al.CG0070,a conditionally replicating granulocyte macrophage colony-stimulating factor-armed oncolytic adenovirus for the treatment of bladder cancer[J].Clin Cancer Res,2006,12(1):305-313.

二级参考文献9

共引文献7

同被引文献19

  • 1张珊文,肖绍文,刘长清,孙艳,苏星,李东明,徐刚,蔡勇,朱广迎,徐博,吕有勇.重组人p53腺病毒注射液联合放射线治疗头颈鳞癌的Ⅱ期临床试验[J].中华医学杂志,2003,83(23):2023-2028. 被引量:70
  • 2陈传本,潘建基,徐鹭英.重组人p53腺病毒注射液结合放射治疗鼻咽癌Ⅱ期临床试验观察[J].中华医学杂志,2003,83(23):2033-2035. 被引量:52
  • 3Chung Moh M, Hoon Lee L,Shen S. Cloning and char- acterization of hepaCAM, a novel Ig-like cell adhesion molecule suppressed in human hepatocellular carcinoma [J]. J Hepatol, 2005,42 : 833-841.
  • 4Xun C,Luo C,Wu X,Zhang Q,Yan L,Shen S. Expres- sion of hepaCAM and its effect on proliferation of tumor cells in renal cell carcinoma[J]. Urology, 2010, 75:828-834.
  • 5He Y,Wu X, Luo C, Lin J. Functional significance of the hepaCAM gene in bladder cancer[J]. BMC Cancer, 2010,10:83.
  • 6Bischoff J R,Kirn D H,Williams A, Heise C, Horn S, Muna M,et al. An adenovirus mutant that replicates se- lectively in p53-deficient human tumor cells [J]. Sci- ence, 1996,274 : 373-376.
  • 7Ehdaie B,Smith S C,Theodorescu D. Personalized med- icine in advanced urothelial cancer., when to treat, how to treat and who to treat[J]. Can Urol Assoc J, 2009,3 (6 Suppl 4) :S232-S236.
  • 8Moh M C,Zhang C, Luo C, Lee L H,Shen S. Structural and functional analyses of a novel Ig-like cell adhesion molecule, hepaCAM, in the human breast carcinoma MCF7 eells[J]. J Biol Chem, 2005,280 : 27366-27374.
  • 9Moh M C, Zhang T, Lee L H, Shen S. Expression of he- paCAM is downregulated in cancers and induces senes- cence-like growth arrest via a p53/p21-dependent path- way in human breast cancer cells[J]. Carcinogenesis, 2008,29 : 2298-2305.
  • 10Rhind N, Russell P. Signaling pathways that regulate cell division[J]. Cold Spring Harb Perspect Biol, 2012, 4 ;a005942.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部